Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tamas Daher
Observed names:
Daher, T.,
Daher, Tamás,
T. Daher
Institution:
University Medical Center of the Johannes Gutenberg University Mainz
Observed institutions:
Justus-Liebig-Universität Gießen,
Universitätsklinikum Gießen und Marburg,
University Medical Center of the Johannes Gutenberg University Mainz
ORCID:
0000-0001-7379-986X
Observed ORCID:
0000-0001-7379-986X
OpenAlex ID:
A5014075787
Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides
2020
·
Ann-Christin Woerl
, Markus Eckstein
, et al.
·
European Urology
·
186
Inhibition of the Cyclin K‐CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer
2023
·
Katharina Frei
, Sabrina Schecher
, et al.
·
International Journal of Cancer
·
17
Combined human papillomavirus typing and TP53 mutation analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma
2018
·
Tamas Daher
, Mehmet Kemal Tur
, et al.
·
Head & Neck
·
11
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer
2024
·
Maximilian P. Brandt
, Olesya Vakhrusheva
, et al.
·
American Journal Of Pathology
·
5
PDF
Overcoming docetaxel resistance in advanced prostate cancer: Analysis of statin therapy from a cell-based model to a patient derived prostate cancer tissue micro array
2023
·
M.P.J.K. Brandt
, O. Vakhrusheva
, et al.
·
European Urology Open Science
Inhibition of the cholesterol metabolism via sterol regulatory element of binding protein (SREB-F1) overcomes docetaxel resistance in advanced prostate cancer
2022
·
M.P.J.K. Brandt
, T. Daher
, et al.
·
European Urology Open Science
Show more works
View as search
Works count:
8
Citation count:
219
H-index:
4
I10-index:
3
Year
Topic
Type